The FDA has approved fezolinetant (Veozah—Astellas Pharma, US).
The drug is a first of its kind nonhormonal therapy for treating menopausal hot flashes. According to the manufacturer, the medication targets a neuron in the brain that is affected by declining estrogen levels.
Learn more here:
https://www.fda.gov/news-events/press-announcements/fda-approves-novel-drug-treat-moderate-severe-hot-flashes-caused-menopause
